相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial
Baroukh M. Assael et al.
JOURNAL OF CYSTIC FIBROSIS (2013)
Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study
Antje Schuster et al.
THORAX (2013)
Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial
Michael W. Konstan et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
Association Between Respiratory Tract Methicillin-Resistant Staphylococcus aureus and Survival in Cystic Fibrosis
Elliott C. Dasenbrook et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Performance of PARI eFlow®
Alan L. Coates
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2010)
An 18-Month Study of the Safety and Efficacy of Repeated Courses of Inhaled Aztreonam Lysine in Cystic Fibrosis
Christopher M. Oermann et al.
PEDIATRIC PULMONOLOGY (2010)
Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis
George Z. Retsch-Bogart et al.
CHEST (2009)
A Gamma Scintigraphy Study to Investigate Lung Deposition and Clearance of Inhaled Amikacin-Loaded Liposomes in Healthy Male Volunteers
Jeffry Weers et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2009)
Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis
Elliott C. Dasenbrook et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis
Karen S. McCoy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Characterization of nebulized liposomal amikacin (Arikace™) as a function of droplet size
Zhili Li et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2008)
Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections
P. Meers et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Cystic fibrosis: A review of epidemiology and pathobiology
Steven D. Strausbaugh et al.
CLINICS IN CHEST MEDICINE (2007)
Mechanisms of disease: Cystic fibrosis
SM Rowe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis
ZH Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis
RB Moss
CHEST (2002)